Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Composite Removable Sinus Stent Post-FESS
NCT02812199Unknown
- Sponsor
- STS Medical Group
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by STS Medical Group. Primary endpoint: Composite Removable Sinus Stent efficacy compared to standard of care at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02812199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812199.